Noninvasive prenatal diagnosis of early onset primary dystonia I in maternal plasma

Prenatal Diagnosis

Volumn 29, Issue 13, 2009, Pages 1218-1221

  Meaney, Cathy ^a   Norbury, G ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

DYT1; Free fetal DNA; Maternal plasma; Noninvasive prenatal diagnosis

Indexed keywords

DNA; ETHIDIUM BROMIDE;

ARTICLE; CLINICAL ARTICLE; DNA EXTRACTION; DYSTONIA; FEMALE; FETUS; FETUS ECHOGRAPHY; GENE MUTATION; GENOTYPE; HUMAN; MATERNAL PLASMA; NON INVASIVE PROCEDURE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL;

DNA; DYSTONIC DISORDERS; FEMALE; HUMANS; MOLECULAR CHAPERONES; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS;

EID: 73449140149     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2385     Document Type: Article

References (17)

1. Chan KC, Zhang J, Hui AB, et al. 2004. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 50: 88-92.
2. Chui RWK, Lau TK, Cheung PT, et al., 2002. Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study. Clin Chem 48(5): 778-780.
3. Chiu RWK, Lau TK, Leung T, et al. 2002. Prenatal exclusion of b-thalassaemia major by examination of maternal plasma. Lancet 360: 98-1000.
4. Costa JM, Benachi A, Gautier E. 2002. New Strategy for prenatal diagnosis of X-linked disorders. N Engl J Med 346: 1502-.
5. Ding C, Chiu RW, Lau TK, et al. 2004. MS analysis of single-nucleotide differences in circulating nucleic acids: application to noninvasive prenatal diagnosis. Proc Natl Acad Sci USA 101: 10762-10767.
6. Faas BH, Beuling EA, Christiaens GC, et al. 1998. Detection of fetal RHD-specific sequences in maternal plasma. Lancet 352: 1196.
7. Finning KM, Martin PG, Soothill PW, Avent ND. 2002. Prediction of fetal D status from maternal plasma: introduction of a new non-invasive fetal RHD genotyping service. Transfusion 42: 1079-1085.
8. González-González MC, Garcá-Hoyos M, Trujillo MJ, et al. 2002. Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma. Prenat Diagn 22(10): 946-948.
9. Li Y, Di Naro E, Vitucci A, et al. 2005. Detection of paternally inherited fetal point mutations for beta-thalassaemia using size-fractionated cell-free DNA in maternal plasma. JAMA 293(7): 843-849; Erratum in: JAMA 2005 Apr 13; 293 14: 1728.
10. Li Y, Holzgreve W, Page-Chistiaens GC, et al. 2004a. Improved prenatal detection of a fetal point mutation for achondroplasia by the use of size-fractionated circulatory DNA in maternal plasma-case report. Prenat Diagn 24: 896-898.
11. Li Y, Zimmermann B, Rusterholz C, et al. 2004b. Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin Chem 50: 1002-1011.
12. Lo YMD, Corbetta N, Chamberlain PF, et al. 1997. Presence of fetal DNA in maternal plasma and serum. Lancet 350: 485-487.
13. Lo YMD, Lo YM, Tein MS, et al. 1998. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for non-invasive prenatal diagnosis. Am J Hum Genet 62(4): 768-775.
14. Ozelius LJ, Hewett JW, Page CE, et al. 1997. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet 17(1): 40-48.
15. Rijinders RJ, van der Schoot CE, Bossers B, et al. 2001. Fetal sex determination from maternal plasma in paregnancies for congenital adrenal hyperplasia. Obstet Gynecol 98(3): 374-378.
16. Saito H, Sekizawa A, Morimoto T, et al. 2000. Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet 356(9236): 1170.
17. Warner TT, Jarman P. 1998. The molecular genetics of the dystonias. J Neurol Neurosurg Psychiatry 64(4): 427-429, Review.